An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury
- 1 February 2011
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 25 (2) , 349-359
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Microglia–neuronal signalling in neuropathic pain hypersensitivity 2.0Current Opinion in Neurobiology, 2010
- Evidence that opioids may have toll-like receptor 4 and MD-2 effectsBrain, Behavior, and Immunity, 2010
- Intrathecal Morphine Attenuates Recovery of Function after a Spinal Cord InjuryJournal of Neurotrauma, 2009
- P2X4-Receptor-Mediated Synthesis and Release of Brain-Derived Neurotrophic Factor in Microglia Is Dependent on Calcium and p38-Mitogen-Activated Protein Kinase ActivationThe Journal of Neuroscience, 2009
- Proinflammatory cytokines oppose opioid-induced acute and chronic analgesiaBrain, Behavior, and Immunity, 2008
- The p38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitroNeuroscience, 1999
- Early neuronal expression of tumor necrosis factor-α after experimental brain injury contributes to neurological impairmentJournal of Neuroimmunology, 1999
- Shock-induced hyperalgesia: II. Role of the dorsolateral periaqueductal gray.Behavioral Neuroscience, 1999
- Evidence That Increased Hippocampal Expression of the Cytokine Interleukin-1β Is a Common Trigger for Age- and Stress-Induced Impairments in Long-Term PotentiationThe Journal of Neuroscience, 1998
- Physiological and pathological roles of interleukin-6 in the central nervous systemMolecular Neurobiology, 1997